Bayer’s Q1 report mentions Nubeqa’s triumph: “Our launch assets Nubeqa™ and Kerendia™ continued to perform particularly well, growing 80 percent year-on-year and reaching combined sales of 680 million euros.”
https://www.bayer.com/media/en-us/2025-bayer-q1-media-update-speech/